A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

(2013) Yehuda Handelsman et al.   Endocrine Practice

Fixed-Dose Combinations for Treatment of Type 2 Diabetes Mellitus

(2012) Lawrence Blonde et al.   ADVANCES IN THERAPY

Fixed-Dose Combination Antidiabetic Therapy: Real-World Factors Associated with Prescribing Choices and Relationship with Patient Satisfaction and Compliance

(2012) Mike Benford et al.   ADVANCES IN THERAPY

Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study

(2012) Michel P. Hermans et al.   CURRENT MEDICAL RESEARCH AND OPINION

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

The Pros and Cons of Diagnosing Diabetes With A1C

(2011) E. Bonora et al.   DIABETES CARE

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

(2011) A. Pfützner et al.   DIABETES OBESITY & METABOLISM

Adding saxagliptin to extended-release metformin vs. uptitrating metformin dosage

(2011) V. Fonseca et al.   DIABETES OBESITY & METABOLISM

Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?

(2010) Bernard Zinman   AMERICAN JOURNAL OF MEDICINE

Saxagliptin and metformin XR combination therapy provides glycemic control over 24 hours in patients with T2DM inadequately controlled with metformin

(2010) Kaj Stenlöf et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus

(2010) André J. Scheen et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial

(2010) B. Göke et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors

(2010) Jaime A. Davidson   MAYO CLINIC PROCEEDINGS

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone

(2009) R. A. DeFronzo et al.   DIABETES CARE

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

(2009) M. Jadzinsky et al.   DIABETES OBESITY & METABOLISM

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

(2009) A. R. Chacra et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone

(2009) Priscilla Hollander et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates

(2008) Min Zhang et al.   BIOMETRICS

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c

(2008) R. M. Cohen et al.   BLOOD

Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among texas medicaid recipients

(2008) Chelim Cheong et al.   CLINICAL THERAPEUTICS

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: A principled yet flexible approach

(2007) Anastasios A. Tsiatis et al.   STATISTICS IN MEDICINE